Ubs Group Ag Shattuck Labs, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 224,766 shares of STTK stock, worth $244,994. This represents 0.0% of its overall portfolio holdings.

Number of Shares

224,766

Previous 11,861 1795.0%

Holding current value

$244,994

Previous $45,000 1642.22%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.0 - $4.85 $638,715 - $1.03 Million	212,905 Added 1795.0%	224,766 $784,000
Q2 2024 Aug 13, 2024	BUY	$3.56 - $11.18 $31,918 - $100,239	8,966 Added 309.71%	11,861 $45,000
Q1 2024 May 13, 2024	BUY	$7.37 - $10.09 $21,336 - $29,210	2,895 New	2,895 $25,000
Q3 2023 Nov 09, 2023	SELL	$1.42 - $3.16 $284 - $632	-200 Reduced 63.69%	114 $0
Q2 2023 Aug 11, 2023	SELL	$2.52 - $3.66 $26,873 - $39,030	-10,664 Reduced 97.14%	314 $0
Q1 2023 May 12, 2023	BUY	$2.5 - $4.72 $10,535 - $19,890	4,214 Added 62.3%	10,978 $32,000
Q4 2022 Feb 08, 2023	BUY	$1.96 - $3.26 $2,412 - $4,013	1,231 Added 22.25%	6,764 $15,000
Q3 2022 Nov 10, 2022	BUY	$2.6 - $5.52 $13,941 - $29,598	5,362 Added 3135.67%	5,533 $15,000
Q2 2022 Aug 10, 2022	BUY	$2.7 - $4.59 $461 - $784	171 New	171 $1,000
Q1 2022 May 16, 2022	SELL	$4.22 - $8.89 $38,735 - $81,601	-9,179 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.36 - $21.08 $76,326 - $192,460	9,130 Added 18632.65%	9,179 $78,000
Q3 2021 Nov 15, 2021	BUY	$17.57 - $28.95 $860 - $1,418	49 New	49 $1,000
Q2 2021 Aug 13, 2021	SELL	$24.14 - $37.68 $438,889 - $685,060	-18,181 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$27.92 - $52.5 $448,423 - $843,202	16,061 Added 757.59%	18,181 $532,000
Q4 2020 Feb 11, 2021	BUY	$19.0 - $57.61 $40,280 - $122,133	2,120 New	2,120 $111,000

Others Institutions Holding STTK

# of Institutions

Shares Held

28.8M

Call Options Held

300

Put Options Held

1.2K

View Full List

About Shattuck Labs, Inc.

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $46.2M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

More about STTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account